Evidence map›Paper›PMID 37036702›Full record

ArticleJAMA neurology2023

Association of Mortality and Risk of Epilepsy With Type of Acute Symptomatic Seizure After Ischemic Stroke and an Updated Prognostic Model.

Lucia Sinka, Laura Abraira, Lukas L Imbach, Dominik Zieglgänsberger, Estevo Santamarina, José Álvarez-Sabín, Carolina Ferreira-Atuesta, Mira Katan, Natalie Scherrer, Giulio Bicciato and 34 more

Open access · greenAbstract read
In one paragraph

Article in JAMA neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 2 pooled it
18.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 2 syntheses or guidelines pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Status epilepticus of carotid web after carotid artery stenting: A case report.The Journal of international medical research · 2025
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 11 countries.

Lucia SinkaDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Laura AbrairaEpilepsy Unit, Department of Neurology, Vall d'Hebron Hospital Universitari, Barcelona, and Universitat Autonoma de Barcelona, Bellaterra, Spain.
Lukas L ImbachSwiss Epilepsy Center, Klinik Lengg, Zurich, Switzerland.
Dominik ZieglgänsbergerDepartment of Neurology, Kantonsspital St. Gallen, St Gallen, Switzerland.
Estevo SantamarinaEpilepsy Unit, Department of Neurology, Vall d'Hebron Hospital Universitari, Barcelona, and Universitat Autonoma de Barcelona, Bellaterra, Spain.
José Álvarez-SabínEpilepsy Unit, Department of Neurology, Vall d'Hebron Hospital Universitari, Barcelona, and Universitat Autonoma de Barcelona, Bellaterra, Spain.
Carolina Ferreira-AtuestaDepartment of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Mira KatanDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Natalie ScherrerDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Giulio BicciatoDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Robert TerzievDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Cyril SimmenDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Kai Michael SchubertDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Adham ElshahabiDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Christian R BaumannDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
Nico DöhlerDepartment of Neurology, Kantonsspital St. Gallen, St Gallen, Switzerland.
Barbara Erdélyi-CanaveseDepartment of Neurology, Kantonsspital St. Gallen, St Gallen, Switzerland.
Ansgar FelbeckerDepartment of Neurology, Kantonsspital St. Gallen, St Gallen, Switzerland.
Philip SiebelDepartment of Neurology, Kantonsspital St. Gallen, St Gallen, Switzerland.
Michael WinklehnerDepartment of Neurology 1, Kepler Universitätsklinikum, Neuromed Campus, Linz, Austria.
Tim J von OertzenDepartment of Neurology 1, Kepler Universitätsklinikum, Neuromed Campus, Linz, Austria.
Judith N WagnerDepartment of Neurology 1, Kepler Universitätsklinikum, Neuromed Campus, Linz, Austria.
Gian Luigi GigliDepartment of Medicine, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
Anna SerafiniDepartment of Medicine, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
Annacarmen NiloDepartment of Medicine, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
Francesco JanesDepartment of Medicine, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
Giovanni MerlinoDepartment of Medicine, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
Mariarosaria ValenteDepartment of Medicine, University of Udine and Clinical Neurology, Udine University Hospital, Udine, Italy.
María Paula Zafra-SierraDepartment of Neurology, Fundación Santa Fe de Bogotá, Universidad de Los Andes, Universidad del Bosque, Bogotá, Colombia.
Hernan Bayona-OrtizDepartment of Neurology, Fundación Santa Fe de Bogotá, Universidad de Los Andes, Universidad del Bosque, Bogotá, Colombia.
Julian ConradDepartment of Neurology, University of Muenster, Muenster, Germany.
Stefan EversDepartment of Neurology, University of Muenster, Muenster, Germany.
Piergiorgio LochnerDepartment of Neurology, Saarland University Medical Center, Homburg, Germany.
Frauke RoellDepartment of Neurology, Saarland University Medical Center, Homburg, Germany.
Francesco BrigoDepartment of Neurology, Hospital of Merano (SABES-ASDAA), Merano-Meran, Italy.
Carla BentesDepartment of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria-CHLN, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Ana Rita PeraltaDepartment of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria-CHLN, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Teresa Pinho E MeloDepartment of Neurosciences and Mental Health (Neurology), Hospital de Santa Maria-CHLN, Centro de Estudos Egas Moniz, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal.
Mark R KeezerStichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
John S DuncanDepartment of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Josemir W SanderDepartment of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Barbara TettenbornDepartment of Neurology, Kantonsspital St. Gallen, St Gallen, Switzerland.
Matthias J KoeppDepartment of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, United Kingdom.
Marian GalovicDepartment of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland.
University of Udine · ITKantonsspital St. Gallen · CHUniversity Hospital of Zurich · CHUniversity of Zurich · CHHospital de Santa Maria · PTEpilepsy Society · GBKepler Universitätsklinikum · ATSaarland University · DEUniversity of Münster · DEVall d'Hebron Hospital Universitari · ESCentre Hospitalier de l’Université de Montréal · CAFundación Santa Fe de Bogotá · COIcahn School of Medicine at Mount Sinai · USKrankenhaus Meran · ITMedical University of Vienna · ATNeurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson · DESwiss Epilepsy Center · CHUniversidad El Bosque · COUniversitat Autònoma de Barcelona · ESUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Acute symptomatic seizures occurring within 7 days after ischemic stroke may be associated with an increased mortality and risk of epilepsy. It is unknown whether the type of acute symptomatic seizure influences this risk. Objective: To compare mortality and risk of epilepsy following different types of acute symptomatic seizures. Design, Setting, and Participants: This cohort study analyzed data acquired from 2002 to 2019 from 9 tertiary referral centers. The derivation cohort included adults from 7 cohorts and 2 case-control studies with neuroimaging-confirmed ischemic stroke and without a history of seizures. Replication in 3 separate cohorts included adults with acute symptomatic status epilepticus after neuroimaging-confirmed ischemic stroke. The final data analysis was performed in July 2022. Exposures: Type of acute symptomatic seizure. Main Outcomes and Measures: All-cause mortality and epilepsy (at least 1 unprovoked seizure presenting >7 days after stroke). Results: A total of 4552 adults were included in the derivation cohort (2547 male participants [56%]; 2005 female [44%]; median age, 73 years [IQR, 62-81]). Acute symptomatic seizures occurred in 226 individuals (5%), of whom 8 (0.2%) presented with status epilepticus. In patients with acute symptomatic status epilepticus, 10-year mortality was 79% compared with 30% in those with short acute symptomatic seizures and 11% in those without seizures. The 10-year risk of epilepsy in stroke survivors with acute symptomatic status epilepticus was 81%, compared with 40% in survivors with short acute symptomatic seizures and 13% in survivors without seizures. In a replication cohort of 39 individuals with acute symptomatic status epilepticus after ischemic stroke (24 female; median age, 78 years), the 10-year risk of mortality and epilepsy was 76% and 88%, respectively. We updated a previously described prognostic model (SeLECT 2.0) with the type of acute symptomatic seizures as a covariate. SeLECT 2.0 successfully captured cases at high risk of poststroke epilepsy. Conclusions and Relevance: In this study, individuals with stroke and acute symptomatic seizures presenting as status epilepticus had a higher mortality and risk of epilepsy compared with those with short acute symptomatic seizures or no seizures. The SeLECT 2.0 prognostic model adequately reflected the risk of epilepsy in high-risk cases and may inform decisions on the continuation of antiseizure medication treatment and the methods and frequency of follow-up.

Indexed as

EpilepsyIschemic StrokeStatus EpilepticusStrokeAdultAgedCohort StudiesFemaleHumansMalePrognosis

Identifiers

PMID37036702
PMCPMC10087089
OpenAlexW4363645872

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.